# ProQR Therapeutics N.V. (PRQR)

> Healthcare · NL · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PRQR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 2.07M | € -13.60M | € -11.49M | € 13.70M | € 37.64M |
| 2025 | € 16.16M | € -42.79M | € -54.40M | € 13.99M | € 49.35M |
| 2024 | € 19.59M | € -28.76M | € -39.17M | € 17.22M | € 88.56M |
| 2023 | € 7.00M | € -29.84M | € 21.41M | € 21.80M | € 45.72M |
| 2022 | € 4.76M | € -70.35M | € -75.58M | € 21.97M | € 67.07M |
| 2021 | € 2.69M | € -73.48M | € -31.60M | € 60.37M | € 113.83M |
| 2020 | € 0 | € -58.29M | € -60.06M | € 41.94M | € 69.85M |
| 2019 | € 0 | € -70.50M | € -55.61M | € 15.22M | € 105.88M |
| 2018 | € 6.25M | € -46.68M | € -39.21M | € 9.39M | € 92.92M |
| 2017 | € -1.96M | € -56.03M | € -45.04M | € 7.24M | € 39.36M |
| 2016 | € 2.97M | € -50.89M | € -47.84M | € 5.70M | € 53.14M |
| 2015 | € 12.38M | € -27.41M | € -33.62M | € 4.84M | € 89.80M |
| 2014 | € 407.5K | € -15.99M | € -20.69M | € 2.86M | € 109.40M |
| 2013 | € 0 | € -3.30M | € -2.31M | € 3.54M | € -89.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.36 |
| Liabilities / Eq | 1.63 |
| Current Ratio | 2.48 |

## Other views

- [Metrics](https://sponda.capital/en/PRQR.md)
- [Charts](https://sponda.capital/en/PRQR/charts.md)
- [Compare](https://sponda.capital/en/PRQR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.